Discovery & Development

Jeroen den Hertog from the Hubrecht Institute is exploring the bioactive properties of fungal strains.

A novel small molecule aims to tackle both Alzheimer’s disease and Dravet syndrome.

Dale Thomas, Co-founder of Mytide, explains how AI can be used for the discovery and development of peptide therapeutics.

As the new virus spreads, more information is needed to mount an appropriate response.

Bacteria shredding liquid metals to fight drug-resistant superbugs.

Can open source by applied to pharma R&D? This is the aim of Molecule.

A new computational tool could help improve the stability and predictability of ADCs.

How will inhaled therapies evolve? Lei Mao at Recipharm gives his take on the future of these therapies.

The cell and gene therapy industry has amazing statistics. But to reach the next level, the industry must address its talent gap.

Contract laboratories need to be treated as equal partners rather than service providers.